Timothy Coughlin sold Travere Therapeutics ($TVTX) shares once on the open market in the last year, totaling about $631 thousand, with the most recent sale on October 31, 2025. His sales rank 5,979th among 11,678 individual insiders, below the average of $8.6 million per seller and 6 transactions. Coughlin made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 31, 2025 | Travere Therapeutics, Inc. | $TVTX | Coughlin Timothy | Not found | M | Common Stock | 10000 | $17.44 | 73,500.0000 | 102,618,560 | 15.75% | 0.01% |
| Oct. 31, 2025 | Travere Therapeutics, Inc. | $TVTX | Coughlin Timothy | Not found | M | Director stock option (right to buy) | 10000 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.01% |
| Oct. 31, 2025 | Travere Therapeutics, Inc. | $TVTX | Coughlin Timothy | Not found | M | Director stock option (right to buy) | 8000 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.01% |
| Oct. 31, 2025 | Travere Therapeutics, Inc. | $TVTX | Coughlin Timothy | Not found | S | Common Stock | 18000 | $35.03 | 55,500.0000 | 102,618,560 | 24.49% | 0.02% |
| Oct. 31, 2025 | Travere Therapeutics, Inc. | $TVTX | Coughlin Timothy | Not found | M | Common Stock | 8000 | $16.33 | 63,500.0000 | 102,618,560 | 14.41% | 0.01% |
| June 3, 2025 | ADC Therapeutics SA | $ADCT | COUGHLIN TIMOTHY | Director | A | Stock Options (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 97,159,966 | 9999.99% | 0.08% |
| June 3, 2025 | ADC Therapeutics SA | $ADCT | COUGHLIN TIMOTHY | Director | A | Common Shares | 40000 | $0.00 | 40,000.0000 | 97,159,966 | 9999.99% | 0.04% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | COUGHLIN TIMOTHY | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | COUGHLIN TIMOTHY | Not found | A | Common Stock | 6500 | $0.00 | 55,500.0000 | 78,888,861 | 13.27% | 0.01% |
| May 1, 2025 | aTYR PHARMA INC | $ATYR | COUGHLIN TIMOTHY | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 88,858,612 | 9999.99% | 0.06% |
| June 7, 2024 | FATE THERAPEUTICS INC | $FATE | COUGHLIN TIMOTHY | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 98,411,162 | 9999.99% | 0.04% |
| May 30, 2024 | aTYR PHARMA INC | $ATYR | COUGHLIN TIMOTHY | Not found | P | Common Stock | 50000 | $1.75 | 56,000.0000 | 0 | 833.33% | 0.00% |
| May 22, 2024 | aTYR PHARMA INC | $ATYR | COUGHLIN TIMOTHY | Not found | A | Stock Option (right to buy) | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | COUGHLIN TIMOTHY | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | COUGHLIN TIMOTHY | Not found | A | Common Stock | 6500 | $0.00 | 49,000.0000 | 74,267,418 | 15.29% | 0.01% |
| June 6, 2023 | FATE THERAPEUTICS INC | $FATE | COUGHLIN TIMOTHY | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |